Reply Memo Turns Abbott Suit More Contentious
The plaintiffs in a class-action lawsuit against Abbott Laboratories Inc. have accused the pharmaceutical giant of introducing new evidence not produced during discovery as part of its efforts to dismiss the...To view the full article, register now.
Already a subscriber? Click here to view full article